Pending CDC approval, the FDA has authorized the use of Pfizer's BioNTech vaccine for distribution among twelve to fifteen year-olds. The vaccine had previously been approved for use in children sixteen and older. The approval should come soon - possibly as soon as Wednesday - and after CDC go-ahead, immunization can begin as early as …
